Quanterix Corporation - Product Pipeline Analysis, 2013 Update - New Market Report

Quanterix Corporation (Quanterix) is a medical device company. The company develops and provides ultra-sensitive detection systems for use in research and in-vitro diagnostics. Its products include simoa HD-1 analyzer, Assay kits and consumables kits. Quanterix applications such as life sciences research (RUO) and oncology, neurology, inflammatory disease, infectious disease. The company offers SiMoA technology that are used by physicians, drug developers and researchers to detect and quantify proteins present in blood and other body fluids at very low and previously undetectable concentrations. Its technology is also used to determine the variation in kinetics among populations of individual enzyme molecules and their interaction partners. Quanterix is headquartered in Lexington, Massachusetts, the US.

Full Report Details at
- http://www.fastmr.com/prod/652432_quanterix_corporation_product_pipeline_analysis.aspx?afid=301

This report is a source for data, analysis and actionable intelligence on the Quanterix Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- Volcano Corporation (VOLC) - Product Pipeline Analysis, 2013 Update
- Quidel Corporation (QDEL) - Product Pipeline Analysis, 2013 Update
- Terumo Corporation (4543) - Product Pipeline Analysis, 2013 Update
- Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis, 2013 Update